Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's Disease: A Case Series Conducted During Lockdown
New Research published in the Photobiomodulation, Photomedicine and Laser Surgery Journal discusses results of an at home trial of SYMBYX Laser devices on participants living with Parkinson's disease. The trial commenced in August 2019 and was based in Sydney, Australia. Lead researcher was Dr Ann Liebert, a Co-Founder of SYMBYX.
Application of light therapy on the gut and back of neck was again shown to be an effective treatment for a number of clinical signs of Parkinson’s, with some improvements being maintained for 45 weeks, despite Covid lockdown restrictions. Participants were assessed for mobility, balance, cognition, fine motor skill and sense of smell on enrolment and again at 12 weeks and after 33 weeks of home treatment. Improvements were similar to those seen in a previous study based in Adelaide (and published in July 2021 in BMC Neurology Journal) which applied light therapy to the gut, back of neck AND the head.